Nitrosoureas as single agents in the treatment of pulmonary cancer.
D002330:Carmustine / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008130:Lomustine / Q000009:adverse effects / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D012673:Semustine / Q000627:therapeutic use
D009607:Nitrosourea Compounds; D012673:Semustine; D008130:Lomustine; D003520:Cyclophosphamide; D002330:Carmustine